Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
Advances in Hematology · 2010 · 2010 · 1-9
DOI: 10.1155/2010/750643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Hematology, 2010. Verfasst von Elizabeta Nemeth. Beteiligte Einrichtung: David Geffen School of Medicine at UCLA, CHS 37-131, 10833 LeConte Avenue, Los Angeles, CA 90095-1690, USA. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The hepatic peptide hormone hepcidin regulates dietary iron absorption, plasma iron concentrations, and tissue iron distribution. Hepcidin acts by causing the degradation of its receptor, the cellular iron exporter ferroportin. The loss of ferroportin decreases iron flow into plasma from absorptive enterocytes, from macrophages that recycle the iron of senescent erythrocytes, and from hepatocytes that store iron, thereby lowering plasma iron concentrations. Malfunctions of the hepcidin-ferroportin axis contribute to the pathogenesis of different anemias. Deficient production of hepcidin causes systemic iron overload in iron-loading anemias such as beta-thalassemia; whereas hepcidin excess contributes to the development of anemia in inflammatory disorders and chronic kidney disease, and may cause erythropoietin resistance. The diagnosis of different forms of anemia will be facilitated by improved hepcidin assays, and the treatment will be enhanced by the development of hepcidin agonists and antagonists.
Autor:innen und Institutionen
- David Geffen School of Medicine at UCLA, CHS 37-131, 10833 LeConte Avenue, Los Angeles, CA 90095-1690, USA.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Nemeth, E. (2010). Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias. Advances in Hematology, 2010, 1-9. https://doi.org/10.1155/2010/750643
Vancouver
Nemeth E. Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias. Advances in Hematology. 2010;2010:1-9. doi:10.1155/2010/750643
BibTeX
@article{Nemeth2010,
author = {Nemeth, Elizabeta},
title = {Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias},
journal = {Advances in Hematology},
year = {2010},
volume = {2010},
pages = {1--9},
doi = {10.1155/2010/750643}
}
EUVIMED